Nipro Corporation

8086.T
Medical Instruments & Supplies
2026/02/16 Updated
Market Cap: $1.6B (¥247.3B)
Stock Price: $9.91 (¥1,516)
Exchange Rate: 1 USD = ¥152.91

Notice Regarding Recording of Special Gain (Gain on Step Acquisition)

In the third quarter of the fiscal year ending March 2026, a special gain of JPY 5,169 million was recorded related to additional acquisition of equity interest in G2/Spryte Holdco, LLC.

Importance:
Page Updated: February 9, 2026
IR Disclosure Date: February 9, 2026

Key Figures

  • Special Gain (Gain on Step Acquisition): JPY 5,169 million (Consolidated cumulative period ending Q3 FY March 2026)
  • Date of Additional Equity Acquisition: 2025-12-19
  • Target Company: G2/Spryte Holdco, LLC (From equity-method affiliate to consolidated subsidiary)

AI要約

Regarding the Recording of Special Gain

On December 19, 2025, the Company additionally acquired equity interest in G2/Spryte Holdco, LLC, which had been an equity-method affiliate, thereby making it a consolidated subsidiary. As a result of remeasuring the equity interest held prior to the additional acquisition at fair value at the time of the acquisition, a special gain (gain on step acquisition) of JPY 5,169 million was recorded in the consolidated cumulative period of Q3 of the fiscal year ending March 2026.

Impact on Performance and Future Outlook

This special gain is already reflected in the Q3 financial summary for the fiscal year ending March 2026. Meanwhile, the full-year consolidated earnings forecast for the fiscal year ending March 2026 remains conservatively unchanged in view of the instability of financial markets and uncertainties in foreign exchange fluctuations. If a revision of earnings guidance becomes necessary, it will be disclosed promptly.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.